Tonix Pharmaceuticals Holding Corp.
Symbol: TNXP (NASDAQ)
31.47
▲ (0.82%) 0.255
Company Description:
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
Key Stats
- Today's Open: $31.335
- Today's High: $31.715
- Today's Low: $31.195
- Today's Volume: 4.41K
- Yesterday Close: $31.21
- Yesterday High: $31.55
- Yesterday Low: $26.8575
- Yesterday Volume: 1.37M
- Last Min Volume: 4
- Last Min High: $31.465
- Last Min Low: $31.465
- Last Min VWAP: $31.465
Company Profile
- Name: Tonix Pharmaceuticals Holding Corp.
- Website: https://www.tonixpharma.com
- Listed Date: 2009-02-13
- Location: CHATHAM, NJ
- Market Status: Active
- CIK Number: 0001430306
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $236.59M
- Round Lot: 100
- Outstanding Shares: 8.77M
- Asset Type: CS
RECENT FILINGS FOR TNXP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-04 | EFFECT | View |
| 2025-09-04 | S-3/A | View |
| 2025-08-21 | 4 | View |
| 2025-08-20 | 4 | View |
| 2025-08-18 | 8-K | View |
| 2025-08-15 | 8-K | View |
| 2025-08-11 | 8-K | View |
| 2025-08-11 | 10-Q | View |
| 2025-07-25 | 8-K | View |
| 2025-07-21 | 8-K | View |
| 2025-07-17 | SCHEDULE 13G | View |
| 2025-07-16 | 8-K | View |
| 2025-07-10 | 8-K | View |
| 2025-07-09 | 8-K | View |
| 2025-07-02 | 8-K | View |
| 2025-06-16 | 8-K | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 3 | View |
| 2025-06-13 | 8-K | View |
| 2025-06-12 | S-3 | View |
Latest News on TNXP